Abbott gets FDA approval for Alinity™ s System

Abbott has announced that U.S. Food and Drug Administration (FDA) appr...

July 15, 2019 | Monday | News
Marken acquires three European logistics companies

Marken have acquired HRTL based in Italy along with two addi...

July 15, 2019 | Monday | News
Janssen submits application to get USFDA nod for DARZALEX

The Janssen Pharmaceutical Companies of Johnson & Johnson has anno...

July 15, 2019 | Monday | News
Jazz Pharma acquires pre-clinical Pan-RAF inhibitor program

Jazz Pharmaceuticals plc has announced that the company has signed a d...

July 11, 2019 | Thursday | News
GSK's 2-drug regimen meets primary goal to control HIV-1

ViiV Healthcare, the global specialist HIV company majority-owned by G...

July 11, 2019 | Thursday | News
Celsius and J&J sign R&D collaboration agreement

Celsius Therapeutics, a company focused on the discovery and developme...

July 12, 2019 | Friday | News
Sandoz extends SYMJEPI™ Injection launch to US

Sandoz Inc. (Sandoz), a Novartis division has announced the US retail ...

July 10, 2019 | Wednesday | News
Lyndra Therapeutics, Gilead Sciences to develop ultra-long-acting HIV therapies

Lyndra Therapeutics, the company making daily pills a thing of the pas...

July 10, 2019 | Wednesday | News
PureTech announces issuance of patent to support its LYT-200 product candidate

PureTech Health, an advanced biopharmaceutical company developing...

July 9, 2019 | Tuesday | News
Cell BT appoints Joshua Ofman to Board of Directors

Cell BT, an immuno-therapy company focused on the discovery and d...

July 9, 2019 | Tuesday | News
BI announces Dabigatran's safety and efficacy for management of VTE in children

Boehringer Ingelheim has announced results from two paediatric studies...

July 9, 2019 | Tuesday | News
WHO prequalifies Mylan HIV self-test

Global pharmaceutical company Mylan N.V. and medical device ...

July 9, 2019 | Tuesday | News
Biocorp strikes €4 M deal with Sanofi for diabetes management

French Company Biocorp has entered into exclusive negotiations with Sa...

July 8, 2019 | Monday | News
Sangamo, Pfizer announce updated Phase 1/2 results for SB-525 investigational Hemophilia A gene therapy

Sangamo Therapeutics, a genomic medicine company, and Pfizer has ...

July 8, 2019 | Monday | News
FSD Pharma closes deal and acquires Prismic Pharmaceuticals

FSD Pharma and Prismic Pharmaceuticals,  a US-based spe...

July 8, 2019 | Monday | News
Facility in Stein (CH) will complement Lonza Pharma & Biotech’s current parenteral drug product offering in Basel (CH)

Lonza has announced its entry into a binding ...

July 5, 2019 | Friday | News
GamaMabs Pharma announces result of murlentamab phase 2 study

GamaMabs Pharma, a clinical stage biotechnology company developing opt...

July 5, 2019 | Friday | News
Appili signs $3M grant contract with the US Defense

Appili Therapeutics Inc. (“Appili”), a biopharmaceutical c...

July 4, 2019 | Thursday | News

Have an Account?

Forgot your password?

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy